Last reviewed · How we verify
platelet-derived repairing factors
At a glance
| Generic name | platelet-derived repairing factors |
|---|---|
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers (NA)
- Application of Growth Factors Derived From Platelets to Accelerate Healing and Reduce Post-extraction Complications in Diabetic Individuals (NA)
- Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors (EARLY_PHASE1)
- Effects of Steroid, Dextrose Prolotherapy, and Platelet-Rich Plasma Injections in Knee Joint OA Patients (NA)
- A Novel Therapeutic Treatment of Pyoderma Gangrenosum (PHASE4)
- Neurorrhaphy Only vs Neurorrhaphy Plus PRF vs Neurorrhaphy Plus Nano-fat in Management of Traumatic Facial Nerve Injury (NA)
- Study on the Use of a Concentrated Growth Factor Preparation Kit for the Treatment of Knee Osteoarthritis (NA)
- Assessment of Growth Factors Levels Associated with Wound Healing After Soft Tissue Crown Lengthening (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: